GIC Private Ltd

GIC Private Ltd sells 10,890,877 shares (31.6% reduction) at $30.54 for $332.6M

GIC Private Ltd, the company's 10% owner, executed two separate sales on 2026-01-29 totaling 10,890,877 shares for $332,552,929.20 at $30.54 per share, reducing holdings from 34,463,633 shares to 23,572,756 shares. The magnitude of this disposition—31.6% of the insider's pre-transaction stake—represents a material reduction in the 10% owner's commitment. Historically, across GIC's open-market sales activity at other tickers, the well-timed rate is 70.00% and the average 90-day return after sells is +1.4%, indicating this insider's prior sales generally occurred before modest subsequent gains. At the same ticker (SARO), 2 of 4 prior sales were well-timed at the 90-day mark. The current stock price of $30.94 is -6.6% from the 52-week high of $33.12, and the 30-day and 90-day price momentum (+4.4% and +12.5% respectively) showed recent strength—context in which a major shareholder liquidates a third of its position. StandardAero's valuation metrics (P/E of 56.25 on $1.5B quarterly revenue and $68.1M net income) reflect a high multiple, suggesting valuation considerations may factor into timing decisions for a block seller of this scale.

GIC Private Ltd (10% owner) purchased 12,586,206 shares for $364,999,974.00 while selling 10,204,351 shares for $289,480,090.47 on 2025-12-18, netting +2,381,855 shares

GIC Private Ltd executed 2 separate transactions on Medline's recent listing date, purchasing 12,586,206 shares at $29.00 and simultaneously selling 10,204,351 shares at $28.37, resulting in a net increase of 2,381,855 shares (+9.6% vs pre-transaction holdings of 24,859,523 shares). The filing shows a deliberate increase in stake shortly after MDLN began trading publicly (4 trading days old), when GIC paid $364,999,974.00 to acquire the larger position despite the offset sale proceeds of $289,480,090.47. A cluster pattern is present: 2 other insiders also purchased within the past 14 days, indicating concurrent buying activity by multiple company stakeholders. The timing coincides with Medline's recent market debut at a price point below the current $42.18, though transaction prices on 2025-12-18 reflect execution at the then-prevailing market levels.

GIC Private Ltd sold 828,729 shares of SARO at $27.30 on 2025-05-29, retaining 34,463,633 shares (34.46M shares) post-transaction.

GIC Private Ltd, a 10% owner, divested 828,729 shares for $22,624,301.70, representing a 2.3% reduction in holdings. The sale occurred at $27.30, currently $2.03 below the prevailing market price of $29.33. At the same-ticker level, GIC has executed three prior trades at StandardAero: a sell on 2024-10-03 showed strong 30-day performance (+25.3%) but only modest 90-day returns (+8.9%), while a more recent sell on 2025-03-27 posted a 30-day loss (-2.5%), suggesting inconsistent timing precision on this specific security. The stock is up 8.6% over 30 days and 3.9% over 90 days from recent lows, trading 11.0% below its 52-week high of $32.97. Fundamentals show revenue of $1,435,588,000.00 and net income of $62,943,000.00, with annual revenue growth of +14.8%, though the P/E of 139.67 reflects elevated valuation expectations relative to current earnings.

GIC Private Ltd sold 5,524,862 shares of SARO at $27.30 for $150.8M, reducing stake from 40.82M to 35.29M shares (-13.5%)

GIC Private Ltd, a 10% owner of StandardAero, divested 5,524,862 shares (5.52M shares) at $27.30 on 2025-05-23, representing a material -13.5% reduction in holdings. The insider's cross-ticker track record shows 8 prior sells with a 71.43% well-timed rate and average 90-day return of +0.9%, suggesting modest historical success in sell timing. However, at StandardAero specifically, prior sales on 2025-03-27 and 2024-10-03 produced mixed outcomes (one currently underwater at -2.5% on 30-day, one well-executed at +8.9% on 90-day), and only 0 of 1 measurable same-ticker sales were well-timed at the 90-day horizon. The company trades at a 136.57 P/E against revenue growth of +14.8% year-over-year and $1.4B quarterly revenue, providing context but not a clear fundamental breakdown signal. The stock currently sits at $28.68, only 2.5% above the sale price, limiting hindsight evidence of poor execution.

GIC Private Ltd (10% Owner) sold 6,629,834 shares of SARO at $27.16 for $180.1M on 2025-03-27, reducing stake by 14.0%.

GIC Private Ltd, a 10% shareholder, divested 6,629,834 shares at $27.16 on 2025-03-27, totaling $180,066,291.44 and reducing holdings from 47,447,058 to 40,817,224 shares. The sale occurred when SARO traded -17.6% below its 52-week high of $32.97 and is currently -0.07% below the execution price. Across all tickers, this insider's prior seven sells averaged +0.9% 90-day returns with a 71.43% well-timed rate (sells where the stock fell afterward), though at SARO specifically, the prior 2024-10-03 sale was poorly timed with a +8.9% 90-day return. The company reports $1.2B quarterly revenue (+14.8% year-over-year growth), but a tight 135.90 P/E ratio and minimal net income of $16.4M suggest growth is pricing in significant execution expectations.

GIC Private Ltd sold 2,900,552 shares of SARO at $22.74, reducing stake from 50.35M to 47.45M shares 4 days before current price of $32.41

GIC Private Ltd, a 10% owner, executed a sale of 2,900,552 shares at $22.74 on 2024-10-03, reducing its position by 5.8% to 47,447,058 shares. Four trading days later, the stock trades at $32.41, representing a 42.6% price appreciation since the sale. Given the recent listing status (4 trading days post-transaction) and the magnitude of the post-sale price movement, this trade warrants examination of whether the company's initial public offering pricing dynamics or the insider's motivations are relevant to current valuation. The sale appears to have been executed well below subsequent market clearing prices, though without pre-IPO context or a FLAG indicating a scheduled trading plan, the timing context remains limited.